Seven days of antibiotics was noninferior to 14 days for treating Gram-negative bloodstream infections, supporting shorter ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

US-based aid group Project Hope, which runs the facility, said the strike occurred as patients had gathered outside to ...

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

A recently published study revealed significant sex-based disparities in emergency department empiric antibiotic treatment ...

ZELSUVMI is now commercially available via prescription through retail pharmacies, ASPN pharmacy services and for at-home delivery through mail-order pharmaciesOnce-daily topical prescription ...

University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides ...

LGBTQ Veteran Finds Closure Through Wish of a Lifetime, learn more about his long-awaited journey Help Register Login Login ...

A study by ICMR's NIE emphasizes the need for year-round surveillance of respiratory infections in Tamil Nadu to enhance ...

Inappropriate polypharmacy—the excessive or unnecessary use of multiple medications—is a major driver of emergency hospital ...

FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation ...